AVTX vs CE · P/E 0.0, rev $441.0K vs rev $10.28B
Avalo Therapeutics Inc (AVTX) versus Celanese Corporation (CE) — a side-by-side from cached financials, not a winner call.
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
Celanese Corporation (CE) is a chemicals company listed on US.
Latest reported AVTX revenue for 2024-12-31 was $441.0K. Net income was -$35.1M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
AVTX currently screens at market cap $51.5M and trailing P/E 0.0. CE currently screens at market cap $5.92B.
Not investment advice. Open the AVTX and CE stock pages for the full models.
Not investment advice.